Circulating Biomarkers
Circulating Biomarkers is a class of biomarkers comprising measurable molecular entities present in biofluids such as blood, urine, or cerebrospinal fluid that originate from diseased tissues or physiological processes and serve as non-invasive indicators of pathological or epigenetic states.
366
Publications
22.2K
Citations
3.3K
Authors
1K
Institutions
Publications per year
2017–2026
203
366
Scott Kopetz, Paulo M. Hoff, Jeffrey S. Morris et al. · Journal of Clinical Oncology · 2009 · 487 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 366
3.3K
4
h-index
4
h-index
4
h-index
3
h-index
3
h-index
1–5 of 3.3K
1K
Harvard University
Cambridge, United States
21 h-index
102 publications
6.5K citations
Massachusetts General Hospital
Boston, United States
14 h-index
58 publications
6.7K citations

Brigham and Women's Hospital
Boston, United States
13 h-index
54 publications
3.6K citations
Inserm
Paris, France
13 h-index
67 publications
5.9K citations
Istituti di Ricovero e Cura a Carattere Scientifico
Rome, Italy
12 h-index
65 publications
4K citations

Karolinska Institutet
Stockholm, Sweden
10 h-index
27 publications
2K citations
Fred Hutch Cancer Center
Seattle, United States
10 h-index
38 publications
7.3K citations
King's College London
London, United Kingdom
8 h-index
13 publications
639 citations
1–8 of 1K
15 publications · 923 citations
14
h-index
IJMS · 11 publications · 449 citations
11
h-index
7 publications · 164 citations
7
h-index
JCEM · 7 publications · 660 citations
7
h-index
CEBP · 6 publications · 153 citations
6
h-index
1–5